Pharma End-to-End Supply Chain 2014


Background Info

The pharmaceutical sector has been impacted by the recent global financial crisis. There are a range of mechanisms that governments are using to rein in pharmaceutical spending and these are being implemented in various ways across the region. And dome of these mechanisms affect the supply chain for pharmaceutical products. Pharma End-to-End Supply Chain 2014 Europe provide an unique platform for business knowledge sharing and convergence of top tier government, hospitals, pharmaceuticals, biotechnology, non-profit organisations, as well as regional and local manufacturers to discuss and share on the macroeconomic factors, policies, issues and drivers that will steer the evolving supply chain in the pharmaceutical industry. Who will you meet: Presidents, Heads/Chiefs, Directors, VPs and Managers of:

  • Supply Chain Strategy & Management
  • Logistics
  • Sourcing/Procurement
  • Distribution
  • Transportation
  • Planning
  • Operations
  • Demand Management
  • Supplier Relations
  • Security
  • Integrity
  • Risk
  • Anti-Counterfeiting


Key Speakers

Janice Kite

Janice Kite, MBA, MCMI, MIBC, Traceability Director Healthcare, GS1 Global Office

Prior to undertaking the assignment with GS1 Global Office to facilitate the development of process and technical Traceability standards, Janice was a senior Manager with responsibility for eBusiness for Johnson & Johnson’s UK Medical Device and Diagnostic companies. This role continued a common thread throughout her career of roles at various stages of the extended supply chain with the trend of moving downstream closer to the external customer. She has held a number of positions with medical device industry associations: ABHI and Eucomed. Her MBA dissertation (Hypothesis: Medical Device manufacturer applied or embedded RFID has benefits to Patient Safety over existing Auto-ID technologies, e.g. Bar Codes) received critical acclaim.

Martin FitzGerald

Martin FitzGerald, deputy to the Director General, GIRP

Martin FitzGerald, deputy to the Director General, advises the association on a matrix of pharmaceutical and legal issues impacting upon the interests of the pharmaceutical full-line wholesale sector in Europe. He also represents the association externally and in this respect works with the European institutions such as the European Commission, the European Parliament and the Council as well as with other European and International organisations such as the Council of Europe and the WHO. Another important part of his work consists in liaising with European stakeholder associations and national health authorities.

Matthew Moran

Matthew Moran, Director, PharmaChemical Ireland

Matthew Moran, Director, PharmaChemical Ireland Matthew Moran is Director of PharmaChemical Ireland. He graduated in Chemistry at Trinity College Dublin in 1980 and in Chemical Engineering at University College Dublin in 1981; he holds an MBA also from University College Dublin (Smurfit School of Business). He worked for over ten years in the pharmaceutical industry where he held a number of management positions both in active ingredient and dosage form manufacture. Matthew Moran is also founder of the Irish BioIndustry Association (IBIA). He is a member the European Chemical Industry Council (CEFIC). Matthew Moran is Vice-President of the Active Pharmaceuticals Ingredients (API) Committee of CEFIC (CEFIC/APIC). PharmaChemical Ireland represents the interests of the pharmachem sector in Ireland. The Irish BioIndustry Association promotes the needs of the biotech sector in Ireland. CEFIC/APIC represents the European API Industry. Matthew is also Director of the Greater Dublin Region of IBEC.

Richard Bergström, Director General, European Federation of Pharmaceutical, Industries and Associations (EFPIA)

Richard Bergström has been the Director General of the European Federation of Pharmaceutical Industries and Associations (EFPIA) since April 2011. Previously he served for nine years as the Director-General of LIF, the Swedish Association of the Pharmaceutical Industry, following positions in Switzerland in regulatory affairs at the pharmaceutical companies Roche and Novartis. Mr Bergström was also appointed by the Swedish Government to the Board of the Karolinska Institute. He is a pharmacist by training, receiving his MScPharm degree from the University of Uppsala, Sweden in 1988.

Christopher Gallwas

Christopher Gallwas, Head of Networking Planning (GPO) Boehringer Ingelheim

Christopher is responsible for all network planning related processes of Boehringer Ingelheim. He ensures the support, harmonization, improvement and implementation of global processes in the area of Demand Planning, Replenishment Planning, Inventory Planning and Target Setting, Sales & Operations Planning, Supply Chain Modelling and Supply Chain Design. Before Christopher joined Boehringer Ingelheim, he has worked as Supply Chain Planning consultant for several companies in the pharmaceutical and chemical industry.


Birk Vanderweeën, Head of Supply Planning Analytics, Global Supply Chain & Strategy, AstraZeneca

As registered Industrial pharmacist and QP, Birk has 20+ years experience in the industry. He has held Leadership roles in Manufacturing, Quality Assurance, Site Management, Supply Chain Management, Logistics and Distribution and have lived and worked in Belgium, UK and Japan. Birk has worked closely with Commercial, to develop innovative and value adding distribution and supply chain solutions and has led multicultural teams and projects across EMEA, Asiapac and globally. He has been a member of Country Senior Leadership Teams in Belgium and Japan. Birk’s current role in Global Supply Chain and Strategy focuses on transforming our supply chains into E2E Value Chains and ensures the capabilities we need to be successful in the future are in place. Birk works in the UK but lives in Belgium with his wife and 2 sons (Thomas and Brent). He likes skiing, mountain biking and is trying to play golf.

michelleMichele Ingravallo, Director of Business Innovation and Transformation in Alliance Boots

Michele Ingravallo is responsible for driving and managing the performance of the Alcura organisation / Brand and businesses related across all the countries and divisional operation, and providing the strategic direction and support to the local operations. Also he is responsible for driving the business innovation process for all the business brands in the pharmaceutical wholesale division of Alliance Boots. He possesses European pharmaceutical experience and he has developed the strategic direction for healthcare and specialised services in the European and Chinese Markets. Michele is a graduate professor in Science, Technology and Maths. He is an MBA Candidate from the University of Bradford – School of Management. Within Alliance Boots, he has held a number of senior positions in the last 9 years where he has developed a series of clinical services for Pharmaceutical Manufacturers, hospitals and CROs. Prior to Alliance Boots, Michele held a number of senior roles in reengineering and consultancy positions in Coca Cola Company, and within the Telecommunication, Bank and the Oil sectors.


Olivier Simonnot has been working for Sensitech Inc.

UTC Building & Industrial Systems, a unit of United Technologies Corp., for seven years and currently holds the position of Strategic Market Manager, Life Sciences EMEA. He previously held several positions in Marketing and Product Management in several international technology oriented companies. He holds a Master of Science in Telecommunications from the French engineering school ESIGETEL and a Master in Business Administration from the Rotterdam School of Management. He is an active member of the French Cold Chain Association, participated in the sub-commission on Metrology and Risk Assessment and is currently active in the Last Mile and New EU GDP working groups.


Jonathan Marshall, Partner, Pricewaterhouse Coopers


Senior Representative


Day 1

08:30 – Registration

09:30 – Chairperson’s Opening Remarks – Janice Kite, Traceability Director Healthcare, GS1

09:40-10:20 – How the European Pharmaceutical-Distribution Landscape Is Today and How Will It Affect Commercial Activities in Europe?

Johnathon Marshall, Pharma & Life Sciences Advisory Director, PwC

10:20-11:00 – Strategic Transformation of Supply Chains

Birk Vanderweeen, VP Global Supply Chain Systems Processes and Analytics, ASTRAZENECA

11:00-11:40 – Morning Refreshment & Networking break – Exhibitors Lounge

11:40 – 12:20 Improve Planning Capabilities and Eliminating Waste in Supply Chains

  • The importance of marketing, sales, and finance departments combined with the latest marketplace intelligence and historical demand data to create a consensus forecast of drugs
  • What are the ways to prioritise forecasting in the supply chain?
  • What are some of the technological tools that could assist in forecasting reliable lead times in the supply chain?
  • Why is product integrity important in helping eliminate waste in supply chain?

Christopher Gallwas, Head of Networking Planning (GPO), Boehringer Ingelheim

12:20-13:00 – GS1 Standards: Foundational to Regulatory Compliance and Improving the Efficiency of Supply Chain

  • Daily interaction is natural and unnoticed
  • The latest in GS1 developments
  • Enabling regulatory compliance, supply chain security and patient safety

Janice Kite, Traceability Director Healthcare, GS1

13:00-14:00 – Networking Lunch

14:00-14:40 – Managing temperature sensitive products in challenging markets: Indian Case Study

  • How to overcome challenges
  • On the ground expertise
  • Specific insight
  • Solution meeting individual needs

Paul Morris, Strategic Account Manager, Life Sciences, Agelity

14:40 – 15:20 – Latest Updates on Europe’s Pharmaceutical Supply Chain Landscape

  • How will the Falsified Medicines Directive (FMD) in Europe increase and significance of local agency oversight and importance of strong supplier relationships?
  • How will the USFDA launch of a new supply chain initiate with EU counterparts improve the quality of pharmaceutical products?

Richard Bergstrom, Director General, EFPIA (European Federation of Pharmaceutical Industries and Associations)

15:20-16:00 – Afternoon Tea Break & Networking

16:00-16:45 – Globalisation and Its Effects on Regulation of the Pharmaceutical Supply Chain

  • How can pharmaceutical companies develop new business opportunities and reduce costs by diversifying the manufacturing supply chain?
  • How can pharmaceutical companies manage their supply chain amidst regulations and compliance, ethics, CSR, social and environmental aspects of emerging markets?


Richard Bergström, Director General, EFPIA (European Federation of Pharmaceutical Industries and Associations)

Jonathon Marshall, Pharma and Life Sciences Advisory Partner, PWC

Oliver Simonnot, Strategic Market Manager Life Science EMEA, Sensitech EMEA, The Netherlands

16:45 -17:00 – Chairperson’s Closing Remark – Janice Kite, Traceability Director Healthcare, GS1

17:00 – 18:00 – Networking Drinks Reception – Take your discussion further to a receptive environment – Exhibitors Lounge

Day 2

08:30 – 09:30 – Registration

09:30 – 09:40 – Chairperson’s Opening Remarks – Paul Morris, Strategic Account Manager, Life Sciences, Agility

09:40 – 10:20 – Key Trends Driving the Need for Supply Chain Security

  • Intentional adulteration, cargo theft, counterfeiting
  • Implementing an end – to – end proactive pharmaceutical supply chain security program
  • Product traceability
  • Compliance with corporate and regulatory group standards

Tom Cochrane, Head of Security Operations, MUNDIPHARMA

10:20 – 11:00 – Clinical and Commercial Drug Supply Chain Management – Concordances and Differences

  • How the use of SAP IT solutions for clinical supply chain management ensures integration with commercial supply chain
  • Particularities of clinical supply chain compared with commercial supply chain dependent on clinical development phase
  • Optimisation and risk avoidance of clinical supply chain supported by simulation
  • Clinical supply chain as pioneer for avoiding fake drugs

Dr. Micahel Richter, Clinical Demand and Supply Leader, Roche

11:00-11:40 – Morning Break & Networking

11:40 -12:20 – Temperature Sensitive Products Supply Chain Integrity

  • Review of Industry trends and increased global regulatory requirements
  • Review of available industry solutions to meet these requirements
  • The benefits of continuous process improvement

Oliver Simonnot, Strategic Market Manager LifeScience EMEA, Sensitech EMEA, The Netherlands

12:20-13:00 – The European Stakeholder Model (ESM) – The Development of a European Medicines Verification System (EMVS)

  • Falsified Medicines Directive and its delegated act on safety features – what its mean for manufacturers, wholesalers and pharmacies
  • Establishing a European Medicines Verification System (EMVS) – What has been done so far
  • Making the European Medicines Verification system (EMVS) work in practice at European and national levels
  • EU hub and first national level experiences

Maarten Van Baelen, Market Access Director, European Generic Medicines Association

13:00-14:00 – Networking Lunch

14:00-14:40 – Managing Healthcare Delivery Channels in the Specialty Market

  • What is the specialty market outlook?
  • How is the market delivering care and therapies to patients?
  • How can the pharmacy play a role within the specialty healthcare provision?

Michele Ingravallo, Director of Business Innovation and Transformation, Alliance Boots

14:40-15:20 – Steering the Future of the Healthcare Supply Chain

  • What are the forces reshaping the environment in which the industry operates and dictating the need for a different sort of Supply chain?

Scott A. Lawson, Director, PwC

15:20-16:00 – Afternoon Tea Break & Networking

16:00-16:40 – What does the future hold for Pharmaceutical supply chain

  • Innovation methods for increasing supply chain visibility
  • Developing a comprehensive risk management strategy
  • Accurately forecasting demand within the supply chain.


Scott A. Lawson, Pharma & Life Sciences Advisory Director, PWC

Birk Vanderweeen, VP Global Supply Chain Systems Processes and Analytics, AstraZeneca

Paul Morris, Strategic Account Manager, Life Science, Agility

16:40 – Chairperson’s Closing Remark – Paul Morris, Strategic Account Manager, LifeSciences, Agility

End of Conference

Sponsors & Exhibitors

sharp-clinicalSharp Clinical Services is a leading provider of specialist clinical supply chain services, from drug product development and manufacturing services through to increasingly complex clinical supplies packaging, clinical labeling and clinical distribution services.

Our experienced project management and operational teams bring together years of unparalleled experience in producing and managing your clinical supply chain across the globe. All projects are compliant with the highest quality standards spanning Good Manufacturing Practices (cGMP), Good Distribution Practices, and all international regulatory requirements. With Sharp Clinical Service’s experience of managing local and global clinical supply chains, access to the world markets just became easier from clinical production, labeling & distribution to comparator sourcing & EU Qualified Person (QP) audit and release services. We are big enough to deliver your global project while remaining small enough to care for your product like our own.

Value Added Services

  • Clinical Supply Chain Optimisation
  • QP Consultancy
  • Project Management
  • Design Engineering
  • Kit/Tooling Design
  • Primary/Secondary Packaging Consultation
  • Protocol Review and Breakdown
  • Import/Export Consultation/Assistance
  • International Shipping Consultation
  • Study Design
  • Drug Forecasting
  • Validation Studies Design
  • Stability Protocol creation
  • R&D Specifications
  • Formulation selection
  • Formula Development Consultation


Sensitech Inc. is a leading provider of supply and cold chain visibility solutions that enable our customers—global leaders in the food, life sciences and industrial markets—to track, monitor and protect the quality and integrity of their temperature-sensitive products across complex supply chains. Through its logistics security division, FreightWatch International, Sensitech also offers origin-to-destination services that provide customers with real-time cargo transparency, helping them to mitigate such risks as theft, diversion, counterfeiting, and chain of custody. Sensitech Inc. is an ISO 9001:2008 company based in Beverly, Mass., with more than 30 sales, service and distribution locations around the world. Sensitech is a part of UTC Building & Industrial Systems, a unit of United Technologies Corp., a leading provider to the aerospace and building systems industries worldwide.


Media Partners

PharmaVOICE magazine provides commentary about the challenges and trends impacting the life-sciences industry, covering a range of issues from molecule through market. PharmaVOICE’s more than 25,000 BPA-qualified subscribers are also kept abreast of the latest trends through additional media resources, including WebSeminars, Podcasts, Videocasts, and White Papers. For further information please visit:

Biocompare is the most comprehensive, in-depth, and objective website for life science product information. Thousands of scientists use Biocompare daily to quickly find the right product for their experiments rather than looking through multiple print catalogs. Visit to find the products you need, stay informed of new technologies, read product reviews, watch product videos, and keep up-to-date on life science news. For further information please visit:

European Life Science is the premier journal devoted to presenting outstanding research and researchers within the life science fields. For further information please visit: is the leading online product and application publication for laboratory scientists featuring the latest news, application articles, videos, product directory and product reviews. Membership is fast, free and provides access to all of the SelectScience services. is a unique video news channel for laboratory application and product information. For further information please visit:

InPharm is the online platform for exclusive pharmaceutical news, comment, contracts, services, jobs and events and is home to, Pharmafile and Pharmafocus. For further information please visit: is the leading industry-sponsored portal for the pharmaceutical sector. Supported by most of the leading pharmaceutical corporations, provides dynamic real-time news, features, events listings and international jobs to industry professionals across Europe and the US. For further information please email:

BIOTECHNOLOGY EUROPE is owned by BIOTECHNOLOGY WORLD. It is based and located in Warsaw, Poland. Biotechnology World was founded in 2007 to provide the world’s biotech and pharma information and market to make it universally accessible and useful for scientific and business processes. Its first step to fulfilling that mission was building the BIOTECHNOLOGY EUROPE platform that will allow a quick spread of information in different channels. BIOTECHNOLOGY EUROPE offers companies completed internet public relations, publication and marketing solutions. One of the mains goals of BIOTECHNOLOGY EUROPE is to integrate the Biotech and Pharma Sector in Europe to global biotechnology, pharmaceutical and life science activities. For further information please visit

Future Pharmaceuticals has forged powerful relationships with key industry leaders to provide a platform for successful brand recognition, and for senior decision- makers to have the means to procure and plan implementation strategies based on the topics covered. Positioned to be an authoritative resource within top pharma companies as well as small, specialty, and biotech, Future Pharmaceuticals magazine is geared to create a deep penetration into a highly targeted and responsive audience, bridging the gap between the industries’ top issues and the solutions top-tier vendors can provide. For further information please visit: